Status:

COMPLETED

Online Intervention to Prevent Perinatal Depression and Promote Breastfeeding

Lead Sponsor:

University of Illinois at Chicago

Conditions:

Depression

Breastfeeding

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

"SunnysidePlus" will functionally integrate a web based intervention targeting skills to promote and support breastfeeding, manage mood,and prevent depression. Sunnyside Plus will build upon the previ...

Eligibility Criteria

Inclusion

  • Female
  • Black or African American
  • 18 years and older
  • Pregnant and between 20 and 28 weeks gestation
  • Intend to breastfeed their child
  • Have a score of 5-14 on the Patient Health Questionnaire-8 (PHQ-8)
  • Have access to a broadband internet connection
  • Are able to read and speak English

Exclusion

  • Are pregnant with multiples
  • Have visual, hearing, voice, or motor impairment that would prevent completion of study procedures
  • Diagnosed with a major depressive episode, psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder or other diagnosis for which participation in this trial is either inappropriate or dangerous based on self-report
  • Are currently receiving treatment (medication or psychotherapy),have an intention to resume antidepressant medication after delivery (i.e., women who discontinued their medication during pregnancy).

Key Trial Info

Start Date :

June 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 15 2021

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT04128202

Start Date

June 15 2020

End Date

July 15 2021

Last Update

July 26 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Illinois at Chicago

Chicago, Illinois, United States, 60612